.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
Updates
After facing criticism about its ability to effectively regulate the drug and device industries, the FDA has been working to increase regulation of drug and device manufacturers. Christine Kain and Christin Garcia discuss the implications of more regulations and possible changes to the 510(k) process for approving medical devices.
Kain and Garcia's article appears in Law360. Read more...
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.
